Latest News View All
Integrated Direct-to-Biology (D2B) Platform
Looking for a solution to accelerate your drug discovery processes? Introducing WuXi AppTec’s Integrated Direct-to-Biology (D2B) platform—a cost-effective and time-saving approach that empowers small molecule...
Continue ReadingWuXi Biology HTS Platform 2.0 Launch
We are excited to announce the official launch of WuXi Biology HTS Platform 2.0, an advanced platform designed to enhance hit discovery and accelerate drug...
Continue ReadingOncoWuXi’s New Antibody Library Launch: An Innovative Step Forward in Drug Development
[Detection Antibodies + Target Development + High-Standard Controls] Empowering the Entire Drug Development Verification Process: In 2024 the OncoWuXi database successfully upgraded to a pharmacology...
Continue ReadingUpcoming EventsView All
September 9, 2025 - September 18, 2025
Copenhagen, Basel, San Diego, and Boston
